IPA logo

ImmunoPrecise Antibodies Ltd. (IPA)

Profile

Full Name

ImmunoPrecise Antibodies Ltd.

Ticker

NASDAQ: IPA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Malaysia

IPO

January 7, 2002

Indexes

Not included

Website

https://www.ipatherapeutics.com

Employees

81

Key Details

Price

$3.20(+21.67%)

Market cap

$147.69M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$17.60M(-3.09% YoY)

Annual EPS

-$0.65(+13.56% YoY)

PE ratio

-

Next earnings date

Sep 16, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.20
    IPA price is $3.20

    30-Day Relative Volume

    1.63
    IPA 30-day relative volume is 1.63

    Price Performance

    Price Most recent change

    +21.67%
    IPA price was up +21.67% on Aug 22, 2025

    Price YTD change

    +676.7%
    IPA price is up +676.7% since January 1st

    Price 1-year change

    +283.23%
    IPA price is up +283.23% year-on-year

    Price 3-year change

    -49.04%
    IPA price is down -49.04% over the past 3 years

    Price Range

    Price All-time high

    $42.75
    IPA price is currently -92.51% below its historical high of $42.75

    Price 3-year low

    $0.27
    IPA price is currently +1085.19% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $147.69M
    IPA market capitalization is $147.69 million

    Market cap 3-year change

    -5.31%
    IPA market capitalization is down -5.31% over the past 3 years

    Market cap All-time high

    $314.32M
    IPA market capitalization is currently -53.01% below its historical high of $314.32 million

    Market cap sector rank

    46.3%
    IPA market capitalization is higher than 46.3% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +69.05%
    IPA shares outstanding is up +69.05% year-on-year

    Shares Outstanding 3-Year Change

    +85.83%
    IPA shares outstanding is up +85.83% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.74
    IPA beta is 0.74

    200-day SMA

    $0.76
    IPA price is currently +321.61% above its 200-day simple moving average

    50-day SMA

    $1.69
    IPA price is currently +89.81% above its 50-day simple moving average

    RSI

    72.09
    IPA 14-day relative strength index is 72.09

    Volume

    1.63
    IPA 30-day relative volume is 1.63

    ATR

    $0.28
    IPA average true range is $0.28

    10-day Historical Volatility

    219.09%
    IPA 10-day historical volatility is 219.09%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $17.60M
    IPA annual revenue is $17.60 million

    Revenue Analysts estimate

    $28.83M
    IPA annual revenue is currently -38.97% lower than the consensus analysts' forecast

    Revenue 1-year change

    -3.09%
    IPA annual revenue is down -3.09% year-on-year

    Revenue Sector rank

    51.61%
    IPA annual revenue is higher than 51.61% of companies in Healthcare sector

    EPS

    EPS

    -$0.65
    IPA annual earnings per share is -$0.65

    EPS Analysts estimate

    -$0.11
    IPA annual earnings per share is currently +501.84% higher than the consensus analysts' forecast

    EPS 1-year change

    +13.56%
    IPA annual earnings per share is up +13.56% year-on-year

    EPS Sector rank

    59.48%
    IPA annual earnings per share is higher than 59.48% of companies in Healthcare sector

    Profit

    Gross profit

    $8.32M
    IPA annual gross profit is $8.32 million

    Gross margin

    47.31%
    IPA annual gross profit margin is 47.31%

    Operating profit

    -$8.74M
    IPA annual operating income is -$8.74 million

    Operating margin

    -50.47%
    IPA annual operating profit margin is -50.47%

    Net income

    -$21.70M
    IPA annual net profit is -$21.70 million

    Net margin

    -123.30%
    IPA annual net profit margin is -123.30%

    Expenses

    Total expenses

    $26.31M
    IPA annual total expenses is $26.31 million

    Operating expenses

    $18.45M
    IPA annual total operating expenses is $18.45 million

    Cost of goods sold

    $9.27M
    IPA annual cost of goods sold is $9.27 million

    Selling, general & administrative expenses

    $13.64M
    IPA annual SGA is $13.64 million

    Depreciation and amortization

    $3.67M
    IPA annual depreciation & amortization is $3.67 million

    Interest expense

    $0.00
    IPA annual interest expense is $0.00

    Income tax

    -$2.89M
    IPA annual income tax is -$2.89 million

    EBIT & EBITDA

    EBIT

    -$24.35M
    IPA annual earnings before interest & taxes is -$24.35 million

    EBITDA

    -$20.68M
    IPA annual EBITDA is -$20.68 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $32.17M
    IPA annual total assets is $32.17 million

    Non current assets

    $18.57M
    IPA annual long term assets is $18.57 million

    Current assets

    $13.56M
    IPA annual total current assets is $13.56 million

    Cash and cash equivalents

    $7.71M
    IPA annual cash & cash equivalents is $7.71 million

    Accounts receivable

    $3.38M
    IPA annual accounts receivable is $3.38 million

    Inventory

    $1.52M
    IPA annual inventory is $1.52 million

    Liabilities

    Total liabilities

    $15.07M
    IPA annual total liabilities is $15.07 million

    Long term liabilities

    $181.00K
    IPA annual total long term liabilities is $181.00 thousand

    Current liabilities

    $6.52M
    IPA annual total current liabilities is $6.52 million

    Accounts payable

    $3.82M
    IPA annual accounts payable is $3.82 million

    Debt

    Total debt

    $9.70M
    IPA annual total debt is $9.70 million

    Total debt 1-year change

    -2.56%
    IPA annual total debt is down -2.56% year-on-year

    Long term debt

    $8.36M
    IPA annual long term debt is $8.36 million

    Short term debt

    $1.34M
    IPA annual short term debt is $1.34 million

    Equity & Capital

    Shareholders equity

    $17.10M
    IPA annual stockholders equity is $17.10 million

    Book value

    $17.08M
    IPA annual book value is $17.08 million

    Retained earnings

    -$93.13M
    IPA annual retained earnings is -$93.13 million

    Working capital

    $7.04M
    IPA annual working capital is $7.04 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$4.59M
    IPA annual cash flow from operations is -$4.59 million

    Cash from operations 1-year change

    -94.85%
    IPA annual cash flow from operations is down -94.85% year-on-year

    Cash from investing

    -$573.40K
    IPA annual cash flow from investing activities is -$573.40 thousand

    Cash from investing 1-year change

    +50.46%
    IPA annual cash flow from investing activities is up +50.46% year-on-year

    Cash from financing

    $10.69M
    IPA annual cash flow from financing activities is $10.69 million

    Cash from financing 1-year change

    +1313.45%
    IPA annual cash flow from financing activities is up +1313.45% year-on-year

    CAPEX

    CAPEX

    $573.40K
    IPA annual capital expenditures is $573.40 thousand

    CAPEX 1-year change

    -44.58%
    IPA annual capital expenditures is down -44.58% year-on-year

    Free Cash Flow

    Free cash flow

    -$5.17M
    IPA annual free cash flow is -$5.17 million

    Free cash flow 1-year change

    -52.31%
    IPA annual free cash flow is down -52.31% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    47.31%
    IPA annual gross profit margin is 47.31%

    Operating margin

    -50.47%
    IPA annual operating profit margin is -50.47%

    Net margin

    -123.30%
    IPA annual net profit margin is -123.30%

    ROA & ROE

    ROA

    -57.22%
    IPA annual return on assets is -57.22%

    ROE

    -100.74%
    IPA annual return on equity is -100.74%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    IPA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    IPA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    8.63
    IPA price to book ratio is 8.63

    PB ratio Sector rank

    86.98%
    IPA price to book ratio is higher than 86.98% of companies in Healthcare sector

    PS Ratio

    PS ratio

    8.41
    IPA price to sales ratio is 8.41

    PS ratio Sector rank

    70.11%
    IPA price to sales ratio is higher than 70.11% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $149.68M
    IPA enterprise value is $149.68 million

    Enterprise value Sector rank

    51.8%
    IPA enterprise value is higher than 51.8% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -7.35
    IPA EV/EBITDA is -7.35

    EV/EBITDA Sector rank

    16.67%
    IPA EV/EBITDA is higher than 16.67% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.08
    IPA annual current ratio is 2.08

    Quick ratio

    1.85
    IPA annual quick ratio is 1.85

    Leverage

    Debt to equity

    0.00
    IPA annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    IPA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    5
    IPA piotroski f-score is 5

    Altman Z-Score

    0.14
    IPA altman z-score is 0.14

    Analyst ratings

    Recent major analysts updates

    Apr 11, 25 HC Wainwright & Co.
    Buy
    Apr 1, 25 Benchmark
    Speculative Buy
    Mar 31, 25 HC Wainwright & Co.
    Buy
    Mar 14, 25 HC Wainwright & Co.
    Buy
    Dec 11, 24 HC Wainwright & Co.
    Buy
    Sep 17, 24 HC Wainwright & Co.
    Buy
    Aug 14, 24 Benchmark
    Speculative Buy
    Jul 30, 24 HC Wainwright & Co.
    Buy
    Mar 15, 24 HC Wainwright & Co.
    Buy
    Mar 15, 24 Benchmark
    Speculative Buy

    Institutional Ownership

    Screeners with IPA included

    Growing Shares Outstanding
    Best performing stocks last month
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biggest stock gainers today
    Best performing stocks YTD
    • What is the ticker symbol for ImmunoPrecise Antibodies Ltd.?
    • Does ImmunoPrecise Antibodies Ltd. pay dividends?
    • What sector is ImmunoPrecise Antibodies Ltd. in?
    • What industry is ImmunoPrecise Antibodies Ltd. in?
    • What country is ImmunoPrecise Antibodies Ltd. based in?
    • When did ImmunoPrecise Antibodies Ltd. go public?
    • Is ImmunoPrecise Antibodies Ltd. in the S&P 500?
    • Is ImmunoPrecise Antibodies Ltd. in the NASDAQ 100?
    • Is ImmunoPrecise Antibodies Ltd. in the Dow Jones?
    • When was ImmunoPrecise Antibodies Ltd.'s last earnings report?
    • When does ImmunoPrecise Antibodies Ltd. report earnings?

    What is the ticker symbol for ImmunoPrecise Antibodies Ltd.?

    The ticker symbol for ImmunoPrecise Antibodies Ltd. is NASDAQ:IPA

    Does ImmunoPrecise Antibodies Ltd. pay dividends?

    No, ImmunoPrecise Antibodies Ltd. does not pay dividends

    What sector is ImmunoPrecise Antibodies Ltd. in?

    ImmunoPrecise Antibodies Ltd. is in the Healthcare sector

    What industry is ImmunoPrecise Antibodies Ltd. in?

    ImmunoPrecise Antibodies Ltd. is in the Biotechnology industry

    What country is ImmunoPrecise Antibodies Ltd. based in?

    ImmunoPrecise Antibodies Ltd. is headquartered in Malaysia

    When did ImmunoPrecise Antibodies Ltd. go public?

    ImmunoPrecise Antibodies Ltd.'s initial public offering (IPO) was on January 7, 2002

    Is ImmunoPrecise Antibodies Ltd. in the S&P 500?

    No, ImmunoPrecise Antibodies Ltd. is not included in the S&P 500 index

    Is ImmunoPrecise Antibodies Ltd. in the NASDAQ 100?

    No, ImmunoPrecise Antibodies Ltd. is not included in the NASDAQ 100 index

    Is ImmunoPrecise Antibodies Ltd. in the Dow Jones?

    No, ImmunoPrecise Antibodies Ltd. is not included in the Dow Jones index

    When was ImmunoPrecise Antibodies Ltd.'s last earnings report?

    ImmunoPrecise Antibodies Ltd.'s most recent earnings report was on March 28, 2025

    When does ImmunoPrecise Antibodies Ltd. report earnings?

    The next expected earnings date for ImmunoPrecise Antibodies Ltd. is September 16, 2025
    On this page